Pharma & Healthcare
Field-force, MR and senior-management mobility.
From medical representatives meeting doctors across cities to clinical-trial site visits and KOL transfers — Commutec supports pharma and healthcare organisations with a chauffeured fleet, dedicated SPOC and audit-ready compliance.
Common requirements
- Medical-representative city travel
- KOL & speaker transfers
- Clinical-trial site logistics
- Conference & symposium delegate movement
Problems this sector faces
The mobility pain-points we see most often in pharma & healthcare — and that most providers don't price into their SLA.
MR productivity ceiling
A medical rep doing 8 doctor calls in Mumbai vs 12 in a managed-mobility city — that 50% productivity gap is the single biggest field-force lever.
MCI/UCPMP compliance optics
How a KOL is transported is now reviewed under fair-market-value norms. Five-star pickups create scrutiny; aggregator cabs create insult.
Clinical-trial site logistics
Investigator visits, patient pickups and sample-courier escort travel are too sensitive for ad-hoc vendors.
Cold-chain & sample-courier mobility
Vaccines and biologics need timed, temperature-aware ground movement — most travel desks improvise this.
The Commutec advantage
MR rental that scales daily
Pay-per-day rep cars with route reporting and doctor-call geo-tags — turn mobility data into a productivity input for sales ops.
UCPMP-aligned KOL playbook
Vehicle grade and pickup protocol matched to specialty and event tier, fully documented for medical-affairs audit.
Sample-courier escort programme
Time-windowed, temperature-aware ground movement with chain-of-custody logs — built with our pharma clients in Mumbai and Hyderabad.
How we deliver
MR mobility
Daily / monthly rental programmes with cost control and route reporting.
KOL chauffeur
Premium vehicles and discreet chauffeurs for high-profile clinicians and speakers.
Other industries
Ready to elevate your corporate mobility?
Speak with a Commutec mobility expert — built for enterprises that demand reliability, transparency and global reach.
